Latest Baxter International Inc (BAX) Headlines
Final Glance: Pharmaceuticals companies
AP - 2 hrs 42 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Final Glance: Medical Devices companies
AP - 2 hrs 42 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Early Glance: Medical Devices companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
United States Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 5:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jjmsm9/united_states) has announced the addition of the "United States Orthobiologics Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Bone Graft Substitutes - Viscosupplementation - Bone Allografts - Bone Growth Stimulators The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. Scope - Market size for Orthobiologics market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the United States Orthobiologics market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution? Identify, understand and capitalize. Key Topics Covered - Introduction - Orthobiologics Market, United States - Overview of Key Companies in United States Orthobiologics Market - Orthobiologics Market Pipeline Products - Financial Deals Landscape - Recent Developments - Appendix Companies Mentioned - Anika Therapeutics - Baxter International - Biomet - DJO Finance - DePuy - Globus Medical - Medtronic - NuVasive - Sanofi - Seikagaku - Smith & Nephew - Stryker - Wright Medical For more information visit http://www.researchandmarkets.com/research/jj...ted_states About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Market Research: Mexico Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/klxv39/mexico) has announced the addition of the "Mexico Orthobiologics Market Outlook to 2020" report to their offering. "Mexico Orthobiologics Market Outlook to 2020", provides key market data on the Mexico Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Mexico Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, Mexico Overview of Key Companies in Mexico Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned Sanofi Medtronic, Inc. DePuy Companies Biomet, Inc. Orthofix International N.V. Stryker Corporation Arthrex, Inc. Wright Medical Group, Inc. DJO Finance LLC Ferring International Center S.A. Baxter International Inc. For more information visit http://www.researchandmarkets.com/research/klxv39/mexico About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research Report - India Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6nzsc6/india) has announced the addition of the "India Orthobiologics Market Outlook to 2020" report to their offering. "India Orthobiologics Market Outlook to 2020", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the India Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, India Overview of Key Companies in India Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned DePuy Companies Sanofi Baxter International Inc. Medtronic, Inc. Orthofix International N.V. Biomet, Inc. Smith & Nephew Plc Wright Medical Group, Inc. Stryker Corporation For more information visit http://www.researchandmarkets.com/research/6nzsc6/india About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016
M2 - Wed Mar 12, 6:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4lq46f/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering. There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011. The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm. Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market. According to the report, one of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Vendor Landscape 8. Buying Criteria 9. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 15. Other Reports in this Series Companies Mentioned: - Advanced Cell Technology Inc. - Arteriocyte Inc. - Athersys Inc. - Baxter International Inc. - CryoLife - Cytori Therapeutics Inc. - Genzyme Corp. - Geron Corp. - InVivo Therapeutics - Inc. - Integra Life Sciences Holdings Corp. - Kensey Nash Corp. - Kinetic Concepts Inc. - Medtronic Inc. - NeoStem Inc. - Osiris Therapeutics Inc. - Osteotech Inc. - RTI Biologics Inc. - Stryker Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/4l...generative
Final Glance: Pharmaceuticals companies
AP - 2 hrs 42 mins ago
NEW YORK (AP) — Shares of some top pharmaceuticals companies were down at the close of trading:
Final Glance: Medical Devices companies
AP - 2 hrs 42 mins ago
NEW YORK (AP) — Shares of some top medical devices companies were down at the close of trading:
Midday Glance: Pharmaceuticals companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
Midday Glance: Medical Devices companies
AP - Thu Mar 13, 12:59PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
Early Glance: Medical Devices companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
Early Glance: Pharmaceuticals companies
AP - Thu Mar 13, 9:16AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
United States Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 5:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jjmsm9/united_states) has announced the addition of the "United States Orthobiologics Market Outlook to 2020" report to their offering. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories: - Bone Graft Substitutes - Viscosupplementation - Bone Allografts - Bone Growth Stimulators The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. Scope - Market size for Orthobiologics market categories. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the United States Orthobiologics market. Reasons to Buy - Develop business strategies by identifying the key market segments poised for strong growth in the future. - Develop market-entry and market expansion strategies. - Design competition strategies by identifying who-stands-where in the market. - Develop investment strategies by identifying the key market segments expected to register strong growth in the near future. - What are the key distribution channels and what's the most preferred mode of product distribution? Identify, understand and capitalize. Key Topics Covered - Introduction - Orthobiologics Market, United States - Overview of Key Companies in United States Orthobiologics Market - Orthobiologics Market Pipeline Products - Financial Deals Landscape - Recent Developments - Appendix Companies Mentioned - Anika Therapeutics - Baxter International - Biomet - DJO Finance - DePuy - Globus Medical - Medtronic - NuVasive - Sanofi - Seikagaku - Smith & Nephew - Stryker - Wright Medical For more information visit http://www.researchandmarkets.com/research/jj...ted_states About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
Market Research: Mexico Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:54AM CDT
Research and Markets (http://www.researchandmarkets.com/research/klxv39/mexico) has announced the addition of the "Mexico Orthobiologics Market Outlook to 2020" report to their offering. "Mexico Orthobiologics Market Outlook to 2020", provides key market data on the Mexico Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the Mexico Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, Mexico Overview of Key Companies in Mexico Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned Sanofi Medtronic, Inc. DePuy Companies Biomet, Inc. Orthofix International N.V. Stryker Corporation Arthrex, Inc. Wright Medical Group, Inc. DJO Finance LLC Ferring International Center S.A. Baxter International Inc. For more information visit http://www.researchandmarkets.com/research/klxv39/mexico About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Research Report - India Orthobiologics Market Outlook to 2020
M2 - Thu Mar 13, 3:32AM CDT
Research and Markets (http://www.researchandmarkets.com/research/6nzsc6/india) has announced the addition of the "India Orthobiologics Market Outlook to 2020" report to their offering. "India Orthobiologics Market Outlook to 2020", provides key market data on the India Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Orthobiologics market wherever available. The data in the report is derived from dynamic market forecast models. The authors use epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers. Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases). Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Market size for Orthobiologics market categories - Bone Graft Substitutes, Viscosupplementation, Bone Allografts and Bone Growth Stimulators. - Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2005 to 2012 and forecast to 2020. - 2012 company shares and distribution shares data for each of the market categories. - Global corporate-level profiles of key companies operating within the India Orthobiologics market. Key Topics Covered: List of Tables List of Figures Introduction Orthobiologics Market, India Overview of Key Companies in India Orthobiologics Market Orthobiologics Market Pipeline Products Financial Deals Landscape Appendix Companies Mentioned DePuy Companies Sanofi Baxter International Inc. Medtronic, Inc. Orthofix International N.V. Biomet, Inc. Smith & Nephew Plc Wright Medical Group, Inc. Stryker Corporation For more information visit http://www.researchandmarkets.com/research/6nzsc6/india About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016
M2 - Wed Mar 12, 6:14AM CDT
Research and Markets (http://www.researchandmarkets.com/research/4lq46f/regenerative) has announced the addition of the "Concise Analysis of the United States Regenerative Medicine Market - Forecasts to 2016" report to their offering. There is a high demand for synthetic organ transplants in the market. Regenerative medicine helps in the development of artificial organs. The introduction of artificial organs for implantation is expected to encourage many vendors and research organizations to develop advanced stem cell products, therapies, and regenerative products. It will also help reduce the long organ waiting list. For instance, custom-made windpipe can be made using regenerative products within a week. The first ever implant of a synthetic trachea took place in June 2011. The synthetic trachea was made from minuscule plastic fibers and was covered in stem cells taken from a human bone marrow. Surgeons successfully implanted this synthetic trachea into a 36-year-old patient with late-stage tracheal cancer at Karolinska University Hospital in Stockholm. Thus, the use of synthetic organs in transplant surgeries is expected to have a positive impact on the growth of the market. According to the report, one of the main drivers of this market is the increasing prevalence of degenerative diseases. Regenerative products have helped in addressing the unmet needs of various disease areas. Another major driver of the market is the significant advances seen in R&D. Key Topics Covered: 1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Market Research Methodology 5. Scope of the Report 6. Market Landscape 7. Vendor Landscape 8. Buying Criteria 9. Market Growth Drivers 10. Drivers and their Impact 11. Market Challenges 12. Impact of Drivers and Challenges 13. Market Trends 14. Key Vendor Analysis 15. Other Reports in this Series Companies Mentioned: - Advanced Cell Technology Inc. - Arteriocyte Inc. - Athersys Inc. - Baxter International Inc. - CryoLife - Cytori Therapeutics Inc. - Genzyme Corp. - Geron Corp. - InVivo Therapeutics - Inc. - Integra Life Sciences Holdings Corp. - Kensey Nash Corp. - Kinetic Concepts Inc. - Medtronic Inc. - NeoStem Inc. - Osiris Therapeutics Inc. - Osteotech Inc. - RTI Biologics Inc. - Stryker Corp. - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/4l...generative
